MDPA
Aliases: Methylenedioxyphenylacetamide
Categories
Summary
An obscure substituted methylenedioxyphenethylamine with practically no history of human use. Its pharmacological profile is largely unknown, but potentially exhibits similar properties to other MDxx compounds. May be a monoamine releaser, reuptake inhibitor or both.
Dose Information
| ROA | Light | Common | Strong | Heavy |
|---|---|---|---|---|
| Oral | 75-125mg | 125-175mg | 175-250mg | 250+mg+ |
Light
Common
Strong
Heavy
Onset, Duration & After-effects
| ROA | Onset | Peak | Total |
|---|---|---|---|
| Oral | 15-45 min | 2.0-4.0 hrs | 120-0 min |
Tolerance
Build-up
develops within days of regular use; analgesic tolerance faster than respiratory depression tolerance
Reset
7–14 days for partial reset; full reset may take weeks — tolerance loss greatly increases overdose risk
Effects
Positive
- Stimulation
Negative
- Increased heart rate
- Pupil dilation
- Teeth grinding
- Nausea
- Vasoconstriction
- Increased perspiration
- Sweating
- Dilated pupils
- Decreased appetite
Positive
- Introspection
- Euphoria
- Wakefulness
- Cognitive euphoria
- Analysis enhancement
- Increased sociability
- Motivation enhancement
Negative
- Anxiety
- Thought acceleration
- Time distortion
Positive
- Color enhancement
- Increased music appreciation
- Tactile enhancement
- Increased libido
- Tracers
- Pattern recognition enhancement
Negative
- Dehydration
- Appetite suppression
- Light sensitivity
- Visual distortions